ApprovalTrail

Approval · Notice of Compliance 2924 · 1998

ACT: Notice of Compliance 2924

Issued February 23, 1998

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
2924
Date
February 23, 1998
Company
Novopharm LimitedMarkham, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Abbreviated New Drug Submission (ANDS)
Submission class
Admin
Therapeutic class
Histamine h2 receptor antagonist

Products in this notice

BrandDINStatus today
ACT02237004Cancelled Pre Market

Medicinal ingredients